Opportunity ID: 130894

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-11-023
Funding Opportunity Title: Bioengineering Interdisciplinary Training and Education for Type I Diabetes Research (T90/R90)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.286 — Discovery and Applied Research for Technological Innovations to Improve Human Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 16, 2011
Last Updated Date:
Original Closing Date for Applications: Mar 14, 2012
Current Closing Date for Applications: Mar 14, 2012
Archive Date: Apr 14, 2012
Estimated Total Program Funding: $1,100,000
Award Ceiling: $250,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement is to promote the development of an interdisciplinary workforce for conducting bioengineering research to develop innovative technologies for treatment of type 1 diabetes including creating integrated long term glucose regulated insulin delivery systems (artificial pancreas), beta cell or islet encapsulation for beta cell replacement therapy, and/or beta cell and autoimmunity imaging methods. This FOA will support institutional training and education programs in type 1 diabetes research for postdoctoral level researchers with backgrounds in bioengineering and/or computational sciences.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-11-023.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-B1 ADOBE-FORMS-B1 PKG00085711 Feb 14, 2012 Mar 14, 2012 View

Package 1

Mandatory forms

130894 RR_SF424_1_2-1.2.pdf

130894 PerformanceSite_1_4-1.4.pdf

130894 RR_OtherProjectInfo_1_3-1.3.pdf

130894 RR_KeyPersonExpanded_1_2-1.2.pdf

130894 RR_Budget-1.1.pdf

130894 PHS398_CoverPageSupplement_1_4-1.4.pdf

130894 PHS398_Checklist_1_3-1.3.pdf

130894 PHS398_ResearchTrainingProgramPlan-1.0.pdf

130894 PHS398_TrainingBudget-1.0.pdf

Optional forms

130894 RR_SubawardBudget-1.2.pdf

130894 PHS_CoverLetter_1_2-1.2.pdf

130894 PHS398_TrainingSubawardBudget-1.0.pdf

2025-07-13T19:31:15-05:00

Share This Post, Choose Your Platform!

About the Author: